Trending Posts

Recent in news
Has China Now Overtaken the US at the…

Recent data from JPM2026 shows that China has surpassed the United States in key biotech activity measures—topping the…

ByByAnuja Singh Mar 4, 2026
Is Hong Kong Becoming Asia’s AI–Biopharma Hub?

Hong Kong is emerging as a key AI‑biopharma hub, with recent deals like Earendil Labs’ partnership with Sanofi…

ByByAnuja Singh Mar 4, 2026
Is Insilico’s AI Drug Engine “Einstein” Turning China…

Insilico Medicine’s AI‑driven drug discovery platform, Pharma.AI “Einstein,” is scaling fast in China, with a major expansion of…

ByByAnuja Singh Mar 4, 2026
Biotech Licensing Soars to $137B in 2025 –…

The global biotech licensing market hit a record $137 billion in 2025, and 2026 is on track to…

ByByAnuja Singh Mar 4, 2026
China Dominates 70% of Global AI Drug Patents:…

China Leads 70% of Global AI Drug Patents: Simple Strategic Snapshot China now holds 70% of the world’s…

ByByAnuja Singh Mar 4, 2026
Merck’s First Fully AI-Designed Oncology Drug: 2027 China…

Merck’s January 26–March 2026 trajectory signals China will approve its first fully AI-designed compound by 2027—the world’s first…

ByByAnuja Singh Mar 4, 2026
Tsinghua’s Agent Hospital Pilots: World’s First AI Hospital…

Tsinghua University’s “world’s first AI Hospital” advanced public pilots February 28-March 2, 2026—deploying 42 AI agents across 300+…

ByByAnuja Singh Mar 4, 2026
DeepSeek AI Hits Hundreds of Hospitals: Pathology Revolution…

DeepSeek chatbot expanded to hundreds of hospitals across Shanghai, Shenzhen, and Chengdu on March 2, 2026—processing 3,000 pathology…

ByByAnuja Singh Mar 4, 2026
China’s $2-3B AI Healthcare Pilots Launch: Rural Revolution…

China’s National Health Commission launched pilots March 1-3, 2026, under its CNY 15-20B ($2-3B) AI strategy—rolling out AI…

ByByAnuja Singh Mar 4, 2026

Latest Stories

Don’t miss our hot and upcoming stories
Has China Now Overtaken the US at the Heart of Biotech Innovation?

Recent data from JPM2026 shows that China has surpassed the United States in key biotech…

ByByAnuja Singh Mar 4, 2026
Is Hong Kong Becoming Asia’s AI–Biopharma Hub?

Hong Kong is emerging as a key AI‑biopharma hub, with recent deals like Earendil Labs’…

ByByAnuja Singh Mar 4, 2026
Is Insilico’s AI Drug Engine “Einstein” Turning China into the Global AI–Pharma Hub?

Insilico Medicine’s AI‑driven drug discovery platform, Pharma.AI “Einstein,” is scaling fast in China, with a…

ByByAnuja Singh Mar 4, 2026
Biotech Licensing Soars to $137B in 2025 – China Now Leads the Licensing Race

The global biotech licensing market hit a record $137 billion in 2025, and 2026 is…

ByByAnuja Singh Mar 4, 2026
Scroll to Top